Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 1
1988 1
1990 2
1993 3
1994 1
1996 1
1997 2
1999 2
2000 2
2001 4
2002 1
2003 1
2004 2
2005 1
2006 3
2007 3
2008 2
2009 1
2010 2
2012 2
2013 1
2014 1
2015 1
2016 2
2017 2
2018 3
2019 1
2020 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
EAA clinical practice guidelines-gynecomastia evaluation and management.
Kanakis GA, Nordkap L, Bang AK, Calogero AE, Bártfai G, Corona G, Forti G, Toppari J, Goulis DG, Jørgensen N. Kanakis GA, et al. Andrology. 2019 Nov;7(6):778-793. doi: 10.1111/andr.12636. Epub 2019 May 16. Andrology. 2019. PMID: 31099174 Free article.
The use of selective estrogen receptor modulators (SERMs), aromatase inhibitors (AIs) and non-aromatizable androgens is not justified in general. Surgical treatment is the therapy of choice for patients with long-lasting GM. SUMMARY OF STATEMENTS (S) AND RECOMMENDATIONS (R …
The use of selective estrogen receptor modulators (SERMs), aromatase inhibitors (AIs) and non-aromatizable androgens is not justified in gen …
Challenges in Prenatal Treatment with Dexamethasone.
McCann-Crosby B, Placencia FX, Adeyemi-Fowode O, Dietrich J, Franciskovich R, Gunn S, Axelrad M, Tu D, Mann D, Karaviti L, Sutton VR. McCann-Crosby B, et al. Pediatr Endocrinol Rev. 2018 Sep;16(1):186-193. doi: 10.17458/per.vol16.2018.mcpa.dexamethasone. Pediatr Endocrinol Rev. 2018. PMID: 30371037 Free PMC article. Review.
Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency causes elevated androgen levels, which can lead to virilization of female external genitalia. Prenatal dexamethasone treatment has been shown to be effective in preventing virilization of …
Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency causes elevated androgen levels, which can lead to viriliza …
Prenatal Diagnosis of Congenital Adrenal Hyperplasia.
Yau M, Khattab A, New MI. Yau M, et al. Endocrinol Metab Clin North Am. 2016 Jun;45(2):267-81. doi: 10.1016/j.ecl.2016.01.001. Epub 2016 Mar 31. Endocrinol Metab Clin North Am. 2016. PMID: 27241964 Review.
To prevent genital ambiguity, in girls, prenatal dexamethasone treatment is administered early in the first trimester. Prenatal genetic diagnosis of CAH and fetal sex determination identify affected female fetuses at risk for genital virilization. ...Cloning of the …
To prevent genital ambiguity, in girls, prenatal dexamethasone treatment is administered early in the first trimester. Prenatal genetic diag …
Management of Infants with Congenital Adrenal Hyperplasia.
Dabas A, Vats P, Sharma R, Singh P, Seth A, Jain V, Batra P, Gupta N, Kumar R, Kabra M, Kapoor S, Yadav S. Dabas A, et al. Indian Pediatr. 2020 Feb 15;57(2):159-164. Indian Pediatr. 2020. PMID: 32060243 Free article. Review.
The role of prenatal steroids to pregnant women with previous history of CAH affected infant for prevention of virilization of female fetus is controversial....
The role of prenatal steroids to pregnant women with previous history of CAH affected infant for prevention of virilization of female …
Management of hirsutism.
Falsetti L, Gambera A, Platto C, Legrenzi L. Falsetti L, et al. Am J Clin Dermatol. 2000 Mar-Apr;1(2):89-99. doi: 10.2165/00128071-200001020-00003. Am J Clin Dermatol. 2000. PMID: 11702316 Review.
GnRH agonists, suppressing the pituitary, decrease androgen and estradiol secretion and improve severe hirsutism. To avoid estrogen deficiency problems, 'add back' therapy with estrogen-progestogen or COCs is advisable. This method of treatment is complicated and expensive …
GnRH agonists, suppressing the pituitary, decrease androgen and estradiol secretion and improve severe hirsutism. To avoid estrogen deficien …
Disorders of sex development: neonatal diagnosis and management.
Paris F, Gaspari L, Philibert P, Maïmoun L, Kalfa N, Sultan C. Paris F, et al. Endocr Dev. 2012;22:56-71. doi: 10.1159/000326631. Epub 2012 Jul 25. Endocr Dev. 2012. PMID: 22846521 Review.
The disorders of sex development (DSD) refer to the insufficient virilization of the external genitalia of a 46,XY fetus or the excessive virilization of those of the 46,XX fetus. ...The impact of environmental endocrine disrupting chemicals during …
The disorders of sex development (DSD) refer to the insufficient virilization of the external genitalia of a 46,XY fetus or th …
Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.
Nimkarn S, New MI. Nimkarn S, et al. Nat Clin Pract Endocrinol Metab. 2007 May;3(5):405-13. doi: 10.1038/ncpendmet0481. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17452967 Review.
In utero gene-specific diagnosis is now feasible for fetal cell samples derived from chorionic villi or amniotic cells in culture, and this gene-specific diagnosis guides the treatment of the affected female fetus. Appropriate dexamethasone administration to the at- …
In utero gene-specific diagnosis is now feasible for fetal cell samples derived from chorionic villi or amniotic cells in culture, an …
Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Nimkarn S, New MI. Nimkarn S, et al. Mol Cell Endocrinol. 2009 Mar 5;300(1-2):192-6. doi: 10.1016/j.mce.2008.11.027. Epub 2008 Dec 3. Mol Cell Endocrinol. 2009. PMID: 19101608 Review.
The most common form of CAH is 21-hydroxylase deficiency (21-OHD), which in its severe form can cause genital ambiguity in females. Affected females experience virilization both physically and psychologically. Steroid 21-OHD can be diagnosed in utero through molecular gene …
The most common form of CAH is 21-hydroxylase deficiency (21-OHD), which in its severe form can cause genital ambiguity in females. Affected …
New developments in prenatal diagnosis of congenital adrenal hyperplasia.
Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T. Kazmi D, et al. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):121-123. doi: 10.1016/j.jsbmb.2016.06.016. Epub 2016 Jul 1. J Steroid Biochem Mol Biol. 2017. PMID: 27378492 Review.
Females affected with classical CAH are at risk for genital ambiguity, but can be treated in utero with dexamethasone before 9 gestational weeks to prevent virilization. Early genetic diagnosis is unavailable through current invasive methods of chorionic villus sampling an …
Females affected with classical CAH are at risk for genital ambiguity, but can be treated in utero with dexamethasone before 9 gestational w …
Prenatal and early postnatal treatment of congenital adrenal hyperplasia.
Ghizzoni L, Cesari S, Cremonini G, Melandri L. Ghizzoni L, et al. Endocr Dev. 2007;11:58-69. doi: 10.1159/000111058. Endocr Dev. 2007. PMID: 17986827 Review.
The objective of prenatal diagnosis and treatment of 21-OH deficiency is the prevention of prenatal virilization in affected female infants, reducing the risks of sex misassignment and gender confusion, and the need for corrective genital surgery. ...
The objective of prenatal diagnosis and treatment of 21-OH deficiency is the prevention of prenatal virilization in affected female i …
50 results